BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25915095)

  • 1. Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.
    Sullivan BP; El-Gendy N; Kuehl C; Berkland C
    Mol Pharm; 2015 Aug; 12(8):2665-74. PubMed ID: 25915095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
    Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
    Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of an In Vitro Model to Assess Delivered Dose and Particle Size for a Vibrating Mesh Nebulizer During Mechanical Ventilation.
    Kadrichu N; Daniher D
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):94-102. PubMed ID: 28813621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.
    Waterer G; Lord J; Hofmann T; Jouhikainen T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31964790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
    Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties.
    Levet V; Merlos R; Rosière R; Amighi K; Wauthoz N
    Int J Pharm; 2017 Jan; 517(1-2):359-372. PubMed ID: 28007545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.
    Garcia-Contreras L; Padilla-Carlin DJ; Sung J; VerBerkmoes J; Muttil P; Elbert K; Peloquin C; Edwards D; Hickey A
    J Pharm Sci; 2017 Jan; 106(1):331-337. PubMed ID: 27842973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose.
    Ung KT; Rao N; Weers JG; Huang D; Chan HK
    Int J Pharm; 2016 Sep; 511(2):1070-9. PubMed ID: 27480399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, dose-response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs.
    Walther FJ; Waring AJ; Otieno M; DiBlasi RM
    Respir Res; 2022 Apr; 23(1):78. PubMed ID: 35379243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
    Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of the DP-4M PennCentury insufflator.
    Hoppentocht M; Hoste C; Hagedoorn P; Frijlink HW; de Boer AH
    Eur J Pharm Biopharm; 2014 Sep; 88(1):153-9. PubMed ID: 24993307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation.
    Cuvelier B; Eloy P; Loira-Pastoriza C; Ucakar B; Sanogo AA; Dupont-Gillain C; Vanbever R
    Int J Pharm; 2015 Nov; 495(2):981-90. PubMed ID: 26456267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
    Stass H; Delesen H; Nagelschmitz J; Staab D
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.